Chairman Li Jingyan of Changchun Changxing Fund, and his delegation visited Sino-tech Healthy

On January 24th, with the recommendation and accompaniment of Xue Fan, Vice General Manager of CSA Applied Chenistry Science&Technology Co., Ltd.(Changchun), ,Chairman Li Jingyan of Changxing Fund, and his delegation visited Jilin Sino-tech healthy Technology Co., Ltd. to discuss investment cooperation matters. Chairman and General Manager Zhang Peibiao, Vice General Manager Li Dongze, and General Manager Assistant Qiang Runrun accompanied the visit and negotiation.

After Chairman Li Jingyan and staff of Changxing Fund in Changchun visited the company, Li Dongze, Deputy General Manager of Sino-tech healthy, gave a detailed introduction to the company's industry university research platform, scientific research achievements, and instrument platform. He also explained in detail the company's current construction situation and future industrial planning, as well as the next step of funding needs and financing plans.

Since its establishment in 2021, Sino-tech healthy has adhered to the development concept of "people-oriented, innovation first", and is based on the "industry university research" cooperation and technological achievement transformation of regenerative medicine technology. After more than 2 years of construction and operation, a production workshop that meets GMP standards and corresponding production equipment and testing instruments have been built. Some products such as recombinant growth factors, microcarriers, and polymers have completed pilot production research, and can achieve small-scale and standardized production. With its advantages of high activity and stability, it has received widespread praise from cooperating units and users. Sino-tech healthy have received support from angel funding projects in Changchun New Area, key cooperation projects between universities and regions in Jilin Province, and technology innovation and entrepreneurship projects for overseas students in Jilin Province. To maintain a competitive advantage in technology, Sino-tech healthy plans to expand the production scale of genetic engineering production lines and promote the research and registration of high-end medical implant materials through financing.

After understanding the Sino-tech healthy's business prospects and development plans, Chairman Li Jingyan showed strong interest in Zhongkekang's research reagents and materials such as growth factors, microcarriers, polymers, as well as the planned launch of medical raw materials and high-end implantable medical devices, and revealed his willingness to further negotiate and cooperate.